Skip to content
SPC Logo

Bramitob Nebuliser Solution

Last Updated on eMC 15-Sep-2015 View document  | Chiesi Limited Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 15-Sep-2015 and displayed until Current

Reasons for adding or updating:

  • Change to section 7 - Marketing authorisation holder
  • Change to section 10 - Date of revision of the text

Date of revision of text on the SPC: 01-Jul-2015

Legal Category:POM

Black Triangle (CHM): NO

Free-text change information supplied by the pharmaceutical company:



Section 7 – Marketing Authorisation Holder - Chiesi Limited, Cheadle Royal Business Park, Highfield, Cheadle, SK8 3GY UK Changed to Chiesi Limited, 333 Styal Road, Manchester, M22 5LG UK

 

Section 10 – Date of revision of the Text – November 2014 changed to July 2015

Updated on 16-Dec-2014 and displayed until 15-Sep-2015

Reasons for adding or updating:

  • Change to section 4.8 - Undesirable effects - how to report a side effect

Date of revision of text on the SPC: 01-Nov-2014

Legal Category:POM

Black Triangle (CHM): NO

Free-text change information supplied by the pharmaceutical company:



In section 4.8 Addition of 'Reporting of suspected adverse reactions' Section

Updated on 24-Oct-2013 and displayed until 16-Dec-2014

Reasons for adding or updating:

  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects

Date of revision of text on the SPC: 01-Jul-2013

Legal Category:POM

Black Triangle (CHM): NO

Free-text change information supplied by the pharmaceutical company:


  • In section 4.4 modest and reversible hypoacusia changed to modest hypoacusia
  • In section 4.8 productive cough changed from common to uncommon

Updated on 02-Nov-2011 and displayed until 24-Oct-2013

Reasons for adding or updating:

  • Change to section 4.2 - Posology and method of administration

Date of revision of text on the SPC: 21-Oct-2011

Legal Category:POM

Black Triangle (CHM): NO

Free-text change information supplied by the pharmaceutical company:

Addition of further drug delivery details

Updated on 05-Sep-2011 and displayed until 02-Nov-2011

Reasons for adding or updating:

  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.8 - Undesirable Effects
  • Change to section 10 date of revision of the text

Date of revision of text on the SPC: 28-Aug-2011

Legal Category:POM

Black Triangle (CHM): NO

Free-text change information supplied by the pharmaceutical company:

Addition of LC Sprint nebuliser and Pari Boy Sx compressor and changes to undesirable effects.

Updated on 03-May-2011 and displayed until 05-Sep-2011

Reasons for adding or updating:

  • Change to section 4.7 - Effects on Ability to Drive and Use Machines
  • Change to section 4.8 - Undesirable Effects
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.4 - Special warnings and precautions for Use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction

Date of revision of text on the SPC: 28-Mar-2011

Legal Category:POM

Black Triangle (CHM): NO

Free-text change information supplied by the pharmaceutical company:

Sections 4.2, 4.4, 4.5, 4.7 & 4.8 updated.

Updated on 05-Aug-2009 and displayed until 03-May-2011

Reasons for adding or updating:

  • Change to section 6. 5 - Nature and Contents of Container

Date of revision of text on the SPC: 23-Mar-2009

Legal Category:POM

Black Triangle (CHM): NO

Free-text change information supplied by the pharmaceutical company:

Pack sizes updated to include full range. 

Updated on 02-Mar-2009 and displayed until 05-Aug-2009

Reasons for adding or updating:

  • Change to section 7 - Marketing Authorisation Holder

Date of revision of text on the SPC: 22-Dec-2008

Legal Category:POM

Black Triangle (CHM): NO

Free-text change information supplied by the pharmaceutical company:

Company name change from Trinity-Chiesi Pharmaceuticals Ltd to Chiesi Ltd

Updated on 28-Jan-2009 and displayed until 02-Mar-2009

Reasons for adding or updating:

  • New SPC for new product

Legal Category:POM

Black Triangle (CHM): NO

Company contact details

Chiesi Limited

Company image
Address

Chiesi Limited, 333 Styal Road, Manchester, M22 5LG

Telephone

0800 009 2329

Telephone

+44 (0) 161 488 5555

Medical Information e-mail

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

tobramycin

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue